Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy

Background/AimsSecond-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma (PDAC) that progresses following gemcitabine-based treatment has not been established. This study aimed to investigate the efficacy and safety of second-line combination chemotherapy with capecitabine...

Full description

Bibliographic Details
Main Authors: Kwang Hyun Chung, Ji Kon Ryu, Jun Hyuk Son, Jae Woo Lee, Dong Kee Jang, Sang Hyub Lee, Yong-Tae Kim
Format: Article
Language:English
Published: Gastroenterology Council for Gut and Liver 2017-03-01
Series:Gut and Liver
Subjects:
Online Access:http://gutnliver.org/journal/view.html?doi=10.5009/gnl16307